TROVATO, Maria Concetta
 Distribuzione geografica
Continente #
NA - Nord America 3.099
EU - Europa 2.267
AS - Asia 1.737
SA - Sud America 733
AF - Africa 55
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 7.903
Nazione #
US - Stati Uniti d'America 3.060
SG - Singapore 762
BR - Brasile 654
IE - Irlanda 533
CN - Cina 524
SE - Svezia 524
UA - Ucraina 252
HK - Hong Kong 232
DE - Germania 230
FR - Francia 195
IT - Italia 169
FI - Finlandia 119
RU - Federazione Russa 96
VN - Vietnam 83
GB - Regno Unito 76
AR - Argentina 36
IN - India 24
BE - Belgio 18
TR - Turchia 18
MA - Marocco 17
CA - Canada 15
BD - Bangladesh 14
MX - Messico 12
IQ - Iraq 11
ZA - Sudafrica 11
UZ - Uzbekistan 9
VE - Venezuela 9
EC - Ecuador 8
NL - Olanda 8
CZ - Repubblica Ceca 7
AL - Albania 6
AZ - Azerbaigian 6
CL - Cile 6
EG - Egitto 6
ES - Italia 6
IR - Iran 6
UY - Uruguay 6
ID - Indonesia 5
KE - Kenya 5
PK - Pakistan 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
CO - Colombia 4
DZ - Algeria 4
EU - Europa 4
JP - Giappone 4
NZ - Nuova Zelanda 4
OM - Oman 4
RO - Romania 4
RS - Serbia 4
BO - Bolivia 3
CI - Costa d'Avorio 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
KR - Corea 3
NP - Nepal 3
TN - Tunisia 3
AU - Australia 2
CH - Svizzera 2
CR - Costa Rica 2
GE - Georgia 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LV - Lettonia 2
MN - Mongolia 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
PT - Portogallo 2
SA - Arabia Saudita 2
SN - Senegal 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
BG - Bulgaria 1
CG - Congo 1
DM - Dominica 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
KH - Cambogia 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MM - Myanmar 1
NG - Nigeria 1
NI - Nicaragua 1
PL - Polonia 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
UG - Uganda 1
Totale 7.903
Città #
Dublin 532
Jacksonville 496
Singapore 357
Chandler 351
Ashburn 306
Dallas 260
Beijing 251
Nyköping 243
Hong Kong 232
Princeton 100
Cambridge 97
Ann Arbor 86
Medford 85
Los Angeles 70
Des Moines 69
Dearborn 60
The Dalles 60
Messina 50
Boardman 44
Buffalo 41
Munich 37
São Paulo 36
Wilmington 34
Woodbridge 31
Bremen 29
Ho Chi Minh City 29
Redondo Beach 29
Jinan 27
Moscow 23
San Mateo 23
Nanjing 22
New York 21
Rio de Janeiro 21
Belo Horizonte 19
Council Bluffs 19
Mazzarra Sant'andrea 19
Brussels 18
Hanoi 17
Houston 16
Shenyang 16
Turku 16
Lancaster 15
Seattle 15
Tianjin 15
Falls Church 14
Brasília 12
Taizhou 12
Hangzhou 11
Santa Clara 10
Zhengzhou 10
Curitiba 9
Haikou 9
Helsinki 9
Ribeirão Preto 9
Guangzhou 8
Sorocaba 8
Acireale 7
Brooklyn 7
Chicago 7
Clearwater 7
Fuzhou 7
Gravataí 7
Hebei 7
London 7
Ningbo 7
Tashkent 7
Auburn Hills 6
Baku 6
Changsha 6
Denver 6
Haiphong 6
João Pessoa 6
Nova Iguaçu 6
Porto Alegre 6
Salvador 6
São José dos Campos 6
Baghdad 5
Betim 5
Buenos Aires 5
Cairo 5
Carapicuíba 5
Casablanca 5
Fortaleza 5
Guarulhos 5
Hyderabad 5
Leawood 5
Manaus 5
Nairobi 5
Norwalk 5
Palermo 5
Piracicaba 5
Pune 5
San Francisco 5
Toronto 5
Ardabil 4
Asunción 4
Atlanta 4
Camaçari 4
Campinas 4
Caxias do Sul 4
Totale 4.702
Nome #
Allelic loss at 7q21 is a frequent and early event in thyroid follicular tumors. 136
Expression of P53 and isoforms in bening and malignant lesions of the head and neck 135
Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: analysis of 318 microdissected thyroid lesions 130
Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor 128
Immunoreactions for P53 isoforms are associated with ultrastructural proliferative profiles in benign thyroid nodules 124
Analisi immunoistochimica dei "pathways" del sistema HGF/c-met in noduli tiroidei benigni e maligni. 122
CD30 and CD30 ligand (CD30L) expression in decidual samples of spontaneous abortions. 121
Cell-specific loss of heterozygosity (LOH) on chromosome 7q21 in thyroid tumors: analysis on 267 laser capture microdissected thyroid lesions 114
Realtà complesse ed epidemiologia di un fenomeno 114
Aplotipi del microsatellite D7S6440, localizzato nell'introne 9 del gene HIPK2, come marcatori molecolari della tiroidite di Hashimoto 112
Cellule giganti tipo corpo estraneo nel carcinoma papillare della tiroide 110
APLOTIPI DEL MICROSATELLITE D7S6440 INTERNO AL GENE HIPK2 COME MARCATORI DELLA TIROIDE AUTOIMMUNITARIA 108
Expression of NA/1 symporter (NIS) in endometrial mucosa of fertile, sterile and post-menopausal women. 104
Expression of CD30 ligand and CD30 receptor in normal thyroid and benign and malignant thyroid nodules 102
Deposito presso la GenBank della sequenza genica del microsatellite di 360 bp denominato “D7S6440”, trovato nell’Homo sapiens, localizzato nel cromosoma 7q 32-34, all’interno del gene HIPK2, a livello dell’introne 9; con tandem di ripetizione fra 173..198 bp costituito da sequenze “ca”. 101
Cancer Thyroid Nodule: Knowing is Doing 100
Serum hepatocyte growth factor is increased in Hashimoto's thyroiditis whether or not it is associated with nodular goiter as compared with healthy non-goitrous individuals 100
Cell-type specifc loss of heterozygosity (LOH) on chromosome 7q21 in thyroid tumors: analysis on 267 laser capture microdissected thyroid lesions 99
Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules 99
Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology 99
CD£0 ligand (CD30L)/CD30 receptor (CD30) signaling in benign and malignant thyroid nodules 98
Coexistence of diffuse large B-cell lymphoma and papillary thyroid carcinoma in a patient affected by hashimoto's thyroiditis 98
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. 98
Compared with healthy controls, serum hepatocyte growth factor (HGF) is increased in the nodular variant of Hashimoto's thyroiditis (HT) more than in the nonnodular variant, whereas serum interleukin-6 (IL-6) is increased regardless of associated thyroid nodules. 97
Hepatocyte growth factor/C-met axis in thyroid cancer: From diagnostic biomarker to therapeutic target 95
The new era of vaccines: the “nanovaccinology” 93
Espressione di CD30 e CD30 ligando nelle decidue di aborti spontanei 91
What is New on Thyroid Cancer Biomarkers 91
HGF/C-MET system pathways in benign and malignant histotypes of thyroid nodules: an immunohistochemical characterization 91
Expressions of Δ 133 isoforms of P53 in multinodular thyroids: the immunoreactions in benign lesions are correlating with subcellular phenotypes of electron microscopy 91
Distinctive expression of STAT3 in papillary thyroid carcinomas and a subset of follicular adenomas 89
Ultrastructural findings of thyrocytes are signatures for an accurate interpretation of cytological aspirates 88
Differential expression of the HGF/c-met ligand/receptor signaling and three downstream molecules (STAT3, PI3K, RHO) in benign and malignant thyroid nodules: possible implications for pharmachologic treatment of the differentiated thyroid cancer (DTC). 87
The tyrosine kinase receptor c-met, its cognate ligand HGF and the tyrosine kinase receptor trasducers STAT3, PI3K and RHO in thyroid nodules associated with Hashimoto's thyroiditis: an immunohistochemical characterization. 87
Immunoexpression of CD30 and CD30 ligand in deciduas from spontaneous abortions 87
Differential expression of the HGF/c-met ligand/receptor signaling and three downstream molecules (STAT3, PI3K, RHO) in benign and malignant thyroid nodules. 85
Combined clinical and ultrasound follow-up assists in malignancy detection in Galectin-3 negative Thy-3 thyroid nodules 85
Immunoexpression of the hepatocyte growth factor (HGF), HGF- receptor (c-met) and STAT3 on placental tissues from malformed fetuses 84
STAT3 is selectively expressed in papillary thyroid cancer (PTC) and some follicular adenomas 84
Multidrug resistance protein 2 (MRP2) nei carcinomi midollari della tiroide 82
Compendio di Anatomia Patologica 82
Multidrug-resistance protein 2 (MRP-2) expression in medullary thyroid carcinoma. 80
Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer 79
Espressione del CDX2 nelle varie fasi dello sviluppo placentare 79
Serum interleukin-6 levels are increased in HIV-infected patients that develop autoimmune disease during long-term follow-up 79
Thyroid hemiagenesis, Graves' disease and differentiated thyroid cancer: a very rare association: case report and review of literature 79
L'espressione di STAT3 èpiù frequentemente associata al sistema HGF7c-met rispetto ad IL-6/IL6R nei carcinomi papillari e negli adenomi follicolari tiroidei 78
Perdita di eterozigosi su 7q21 nella patologia multinodulare della tiroide 78
METODO PER LA DIAGNOSI IN VITRO DI CARCINOMA TIROIDEO 78
Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness. 77
Multidrug resistance protein-2 (MRP-2) nel carcinoma midollare della tiroide. 77
New Research Communication on Thyroid Tumor Markers 77
TP53 polymorphism may contribute to genetic susceptibility to develop Hashimoto's thyroiditis 76
LACK OF SOMATOSTATIN ANALOGS (SSAS) EFFECTIVENESS IN GONADOTROPIN-SECRETING PITUITARY ADENOMAS: REPORT OF A CASE AND A REVIEW OF THE LITERATURE 75
The loss of the p53 activator HIPK2 is responsible for galectin-3 overexpression in well differentiated thyroid carcinomas 75
Espressione immunoistochimica di HGF, c-met e STAT3 in placente da gravidanze con feti malformati 74
Expression of transcription factor STAT3 associated to HGF/c-met system in normal and pathological thyroid tissue. 73
Infezione occulta da virus dell’epatite B in pazienti con epatite cronica virus con correlata valutazione istologica 72
EGF, TGFA-apla, EGF receptor (EGFR) and somatostatin receptors (SSR2) in acanthosis nigricans (AN) 71
Loss of heterozygosity for 7q21.1 and 31.3 is peculiar of follicular and anaplastic, but not papillary, thyroid cancers 71
EGF, TGF-alpha, EGF receptor (EGFR) and somatostatin receptors 2 (SSR2) in acanthosis nigricans (AN) 71
Expression of hepatocyte growth factor in Hashimoto's thyroiditis with nodular lesions 70
Immunoexpression of multidrug-resistance protein 2 and cyclooxygenase 2 in medullary thyroid carcinomas 70
Repression of the Antiapoptotic Molecule Galectin-3 by Homeodomain-Interacting Protein Kinase 2-Activated p53 Is Required for p53-Induced Apoptosis. 69
La perdita di eterozigosità (LOH) per markers sul braccio lungo del cromosoma 7 (7q) è peculiare dei carcinomi tiroidei follicolari (FTC) e anaplastici (ATC), non dei papillari (PTC). 68
SELECTIVE RADIO-GUIDED NECK DISSECTION FOR CERVICAL LYMPH NODE METASTASIS FROM OCCULT THYROID CANCER: REPORT OF A CASE 68
Nanostructures: between natural environment and medical practice. 68
Immunodimostrazione dell'antigene K-1 (CD30) nella patologia autoimmune e neoplastica della tiroide. 67
Prognostic and predictive biomarkers in thyroid diseases: “magic bullets” for a personalized therapeutic strategy 67
LOH sul braccio lungo del cromosoma 7 è una frequente alterazione genetica nel carcinoma follicolare ed anaplastico della tiroide. 66
Distinctive expression of STAT3 in papillary thyroid carcinoma and a subset of follicular adenomas. 66
Expression of transcription factor STAY3 associated to HGF/c-met and IL-6/IL-6r sistems in normal and pathologic thyroid tissue 65
Hepatocyte growth factor (HGF) expression and circulating levels in nodular Hashimoto's thyroiditis. 65
EXPRESSION IN DECIDUAL SAMPLES OF SPONTANEOUS ABORTIONS. 64
Espressione genica della via p53/HGF/c-met /STAT3 nei feti con malformazioni del sistema nervoso. 63
MULTIDRUG-RESISTANCE PROTEIN 2 (MRP2) E CICLO-OSSIGENASI 2 (COX2) NEL CARCINOMA MIDOLLARE DELLA TIROIDE. 63
Espressione dei fattori della morfogenesi negli organi e nelle placente di feti a varie epoche di gestazione 62
Expression of IL6/IL6R and CD30L/C30 in normal thyroid and thyroid nodules. 62
New Research Communication on Thyroid Tumor Markers 62
Serum Levels And Immohistochemical Expression Of Hepatocyte Growth Factor (Hgf) in Hashimoto Thyroiditis 61
Loss of heterozygosity of 7q21.1 and 7q31.3 is peculiar of follicular and anaplastic, but not papillary, thyroid cancer. 61
THE LOSS OF THE P53 ACTIVATOR HIPK2 IS RESPONSIBLE FOR GALECTIN-3 OVEREXPRESSIONIN WELL DIFFERENTIATED THYROID CARCINOMAS 61
Immunoexpression of the CD30 ligand/CD30 and IL-6/IL-6R signals in thyroid autoimmune diseases 60
Serum Amyloid A (SAA) expression by medullary thyroid cancer (MTC). 60
Espressione dlel'hepatocyte growth factor (HGF) e del suo recettore (HGF-R o c-met) nei carcinomi papillari tiroidei. 59
Expression of p53/ HGF/c-met/ STAT3 signal in fetus with malformation of nervous system. 57
The use of Laser Capture Microdissection in the identification of new putative oncosoppressor genes in thyroid cancer. 57
Serum amyloid A (SAA) expression in medullary thyroid cancer (MTC). 56
Hepatocyte growth factor (HGF) expression in nodular Hashimoto thyroditis. 56
Serum levels and immunohistochemical expression of Hepatocyte Growth Factor (HGF) in Hashimoto thyroiditis. 55
Serum levels and immunochemical expression of hepatocyte growth factor (HGF) in Hashimoto's thyroiditis. 55
Single Nucleotide Polymorphisms (SNPs) in exon 4 of p53 as genetic markers of susceptibility for Hashimoto’s thyroiditis (HT) 55
Expression of HGF and HGF-receptor (c-met) in the papillary thyroid cancer (PTC). 54
Polimorfismo dle gene TP53 nrlla tiroidite di Hashimoto (TH). 54
Interleukin‑6 signalling as a valuable cornerstone for molecular medicine 52
Dimostrazione immunocitochimica dell'Hepatocyte Growth Factor (HGF) e del suo recettore c-met nel tessuto tiroideo normale e patologico. 48
Expression of p53/hgf/c-met/STAT3 signal in fetuses with neural tube defects 47
Papillary and follicular thyroid carcinomas show LOH in two distinct regions of the long arm of chromosome 7 47
Immunohistochemical expression of HGF, c-met and transcription-factor STAT3 in colorectal tumors. 47
Specific haplotypes of a microsatellite markers internal to the HIPK2 gene in Hashimoto thyroditis 46
Totale 7.993
Categoria #
all - tutte 31.280
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.280


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021319 0 0 0 0 0 88 8 64 7 65 59 28
2021/2022683 6 86 20 34 31 7 44 32 14 110 103 196
2022/20231.524 123 107 64 102 123 171 16 94 653 3 55 13
2023/2024332 31 60 31 46 39 48 4 34 0 7 2 30
2024/20251.732 15 32 35 115 73 80 16 421 441 80 107 317
2025/20261.566 222 311 278 295 430 30 0 0 0 0 0 0
Totale 8.011